Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 8-K Event Results of operations
  2. 8-K Event Material agreement
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Executive or director change
  5. 8-K Event Regulation FD disclosure
  6. 10-Q Report Quarterly Report
  7. 10-K/A Report 10-K/A
  8. 8-K Event Results of operations
  9. 8-K Event Delisting notice
  10. 8-K Event Regulation FD disclosure
  11. NT 10-Q Other NT 10-Q
  12. 4 Grant or award SVP, CFO and Treasurer acquired 370,000 shares (grant or award)
  13. 8-K Event Executive or director change
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Regulation FD disclosure · Other events
  16. 8-K Event Executive or director change
  17. 8-K Event Executive or director change · Shareholder vote results
  18. 4 Grant or award Director acquired 30,000 shares (grant or award)
  19. 4 Grant or award Director acquired 30,000 shares (grant or award)
  20. 4 Grant or award Director acquired 30,000 shares (grant or award)

Page 10 of 45 · 886 filings